Recent Updates
Recently added Catalysts
RMD Positive Sentiment

Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026

Key Takeaway: Resmed has announced that it will release its financial results for the fourth quarter of fiscal year 2026 on August 6, 2026. Following the release, management will host a webcast to discuss the results and other material information. The webcast will be accessible via their investor relations website.
Price reaction · baseline $194.88 (2026-06-30 close) · hit after-hours · 1 other RMD headline(s) in the window, move may be shared
day 0 close · peak
+3.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Resmed is committed to innovative health technologies.
  • The upcoming earnings report shows transparency and engagement with investors.
  • The webcast allows for direct communication of results and future outlook.

Full Press Release Details

SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
• Date:               Thursday, August 6, 2026
• Time:               1:30 p.m. PT / 4:30 p.m. ET
• International:   London, Thursday, August 6, 2026, 9:30 p.m. BSTSydney, Friday, August 7, 2026, 6:30 a.m. AEST
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from August 6, 2026, until August 20, 2026, at:
• U.S.: +1 877.660.6853
• International: +1 201.612.7415
• Conference ID: 13761408
About ResmedResmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors For media
+1 858.221.3304 +1 619.510.1281
investorrelations@Resmed.com news@Resmed.com

Frequently Asked Questions

When will Resmed report its Q4 fiscal 2026 earnings?

Resmed will report its Q4 fiscal 2026 earnings on August 6, 2026.

How can I access Resmed's earnings webcast?

The earnings webcast can be accessed via Resmed's investor relations website.

What time is the Resmed earnings call scheduled?

The earnings call is scheduled for 1:30 p.m. PT on August 6, 2026.

Will there be a replay of the earnings webcast?

Yes, a replay will be available on Resmed's investor relations website after the webcast.

Last updated: Jun 30, 2026